CD4 and metabolic dysfunction-associated steatotic liver disease: Taken together, our results show that populations of multicytokine-producing CD4+ T cells were significantly enriched in the liver of the NASH patients and we were able to distinguish between NAFLD and NASH patients in combination with clinical parameters.